Fas (CD95) expression

From: Michel Canton (mcanton@wcube.fr)
Date: Mon Dec 22 1997 - 04:32:14 EST


Hello, everyone,

Following a last discussion on the List about CD45RA and memory cells,
Philippe Poncelet and I would like to share with you some observations we
made in quantifying the expression of Fas receptor (CD95) on HIV-infected
patients.
We used our recently commercialized APOCYT Fas (Cell) kit. This is another
of our Quantitative Flow Cytometry application kits. 
Healthy donors express 2 very well defined subsets of T-lymphocytes. The
first one is a Fas (low) population expressing  less than 2,000 Fas per
cell. The second subset is Fas (high) with over 2,000 up to 20,000 Fas per
cell. The distinction between both supopulations is very easy when using
quantitative flow cytometry and since the reproducibility of our kit is
remarkable, we were able to define the 2,000 value as a differentiation
criteria between the subsets. The relative distribution of both
subpopulations looks rather similar to that of CD45RO (low) and CD45RO (high).
According to the literature Fas (high) T cells proportion increases with age
and the Fas (high) phenotype is often related to chronically
activated/memory T cells.
Then we measured the expression of Fas on T cells from HIV-infected patients
and found that only Fas (high) T cells were present in the samples of the
small series we tested. Since the literature describes significant, although
low, residual CD45RA+ T cells in HIV patients, we wonder whether the absence
of Fas (low) T cells could be explained by the few remaining CD45RA+ being
activated/memory T cells.
Silly question, may be: could high expression level of Fas also be a
valuable marker for memory cells?

By the way we also tested few bone marrow transplant patients using APOCYT
Fas (cell) and also found a majority of Fas (high) T (CD3-PE+) lymphocytes.

Anyone with thoughts and comments about these results?

Happy Holiday Season and Greetings from France

Michel Canton, PharmD
Philippe Poncelet, PhD
BioCytex

Tel: +33 (0)  4 91 94 29 39
Fax: +33 (0) 4 91 47 24 71



This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:50:26 EST